The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $70.14

Today's change-0.96 -1.35%
Updated February 27 4:01 PM EST. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $70.14

Today's change-0.96 -1.35%
Updated February 27 4:01 PM EST. Delayed by at least 15 minutes.

Quest Diagnostics Inc down (U.S.)$0.96

Quest Diagnostics Inc closed lower Friday, dropping (U.S.)$0.96 or 1.35% to (U.S.)$70.14. Shares have lost 2.27% over the last five days, but sit 3.73% below their 52-week high. This security has outperformed the S&P 500 by 19.45% during the last year.

Key company metrics

  • Open(U.S.) $70.94
  • Previous close(U.S.) $71.10
  • High(U.S.) $71.10
  • Low(U.S.) $69.96
  • Bid / Ask(U.S.) $68.10 / (U.S.) $73.73
  • YTD % change+4.59%
  • Volume1,839,536
  • Average volume (10-day)1,224,138
  • Average volume (1-month)1,588,795
  • Average volume (3-month)1,459,873
  • 52-week range(U.S.) $51.86 to (U.S.) $72.86
  • Beta0.67
  • Trailing P/E18.53×
  • P/E 1 year forward14.93×
  • Forward PEG1.85×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.17%
  • Trailing EPS(U.S.) $3.79
Updated February 27 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.90%

Based on its net profit margin of 7.90%, Quest Diagnostics Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue1,8831,9041,9021,746
Total other revenue--------
Total revenue1,8831,9041,9021,746
Gross profit699733732653
Total cost of revenue1,1841,1711,1701,093
Total operating expense1,6261,6481,6401,538
Selling / general / administrative427437434411
Research & development--------
Depreciation / amortization23242522
Interest expense (income), net operating--------
Unusual expense (income)0161012
Other operating expenses, total-8010
Operating income257256262208
Interest income (expense), net non-operating---42-42-40
Gain (loss) on sale of assets--------
Other--------
Income before tax223221229176
Income after tax195139142111
Income tax, total28828765
Net income190129133104
Total adjustments to net income0-10-1
Net income before extra. items185129133104
Minority interest-10-10-9-7
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items185128133103
Inc. avail. to common incl. extra. items190128133103
Diluted net income190128133103
Dilution adjustment0------
Diluted weighted average shares146145145145
Diluted EPS excluding extraordinary itemsvalue per share1.270.880.920.71
Dividends per sharevalue per share0.330.330.330.30
Diluted normalized EPSvalue per share1.270.950.960.76